Effects of MDMA on body temperature in humans
Temperature October 31, 2014 DOI: 10.4161/23328940.2014.955433 via OpenAlex
Summary
AI-generated from the abstractMDMA (Ecstasy) causes a dose-dependent rise in core body temperature of 0.2–0.8°C in healthy subjects under controlled conditions, but moderately hyperthermic temperatures above 38.0°C occur frequently at higher doses even without physical activity. The hyperthermia results from MDMA releasing norepinephrine, which increases metabolic heat generation and causes cutaneous vasoconstriction that impairs heat dissipation. The role of serotonin is unclear. Severe hyperthermia is managed with sedation, intravenous fluids, cooling, and mechanical ventilation.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Population | Healthy subjects |
| Topics | MDMA Serotonin |
| Keywords | Hyperthermia Norepinephrine |
| Citations | 64 |
| Key finding | MDMA produces an acute, dose-dependent rise in core body temperature in humans, partially mediated by norepinephrine release, with moderately hyperthermic temperatures occurring at higher doses even without physical activity. |
Abstract
Hyperthermia is a severe complication associated with the recreational use of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy). In this review, the clinical laboratory studies that tested the effects of MDMA on body temperature are summarized. The mechanisms that underlie the hyperthermic effects of MDMA in humans and treatment of severe hyperthermia are presented. The data show that MDMA produces an acute and dose-dependent rise in core body temperature in healthy subjects. The increase in body temperature is in the range of 0.2-0.8°C and does not result in hyperpyrexia (>40°C) in a controlled laboratory setting. However, moderately hyperthermic body temperatures >38.0°C occur frequently at higher doses, even in the absence of physical activity and at room temperature. MDMA primarily releases serotonin and norepinephrine. Mechanistic clinical studies indicate that the MDMA-induced elevations in body temperature in humans partially depend on the MDMA-induced release of norepinephrine and involve enhanced metabolic heat generation and cutaneous vasoconstriction, resulting in impaired heat dissipation. The mediating role of serotonin is unclear. The management of sympathomimetic toxicity and associated hyperthermia mainly includes sedation with benzodiazepines and intravenous fluid replacement. Severe hyperthermia should primarily be treated with additional cooling and mechanical ventilation.